Novel therapeutic targets in the treatment of IBD
Author:
Publisher
Informa Healthcare
Subject
Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1517/14728222.12.5.553
Reference84 articles.
1. A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease
2. Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease
3. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
4. Infliximab Maintenance Therapy for Fistulizing Crohn's Disease
5. Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. IL-20 controls resolution of experimental colitis by regulating epithelial IFN/STAT2 signalling;Gut;2023-10-26
2. Intestinal CD11b+ B Cells Ameliorate Colitis by Secreting Immunoglobulin A;Frontiers in Immunology;2021-11-03
3. MiR-146b-5p targets IFI35 to inhibit inflammatory response and apoptosis via JAK1/STAT1 signalling in lipopolysaccharide-induced glomerular cells;Autoimmunity;2021-08-26
4. Xinhuang Tablets Improve Intestinal Barrier Function via Regulating Epithelial Tight Junctions in Dextran Sulfate Sodium-Induced Ulcerative Colitis Mice;Journal of Medicinal Food;2021-01-01
5. CTLA-4: From mechanism to autoimmune therapy;International Immunopharmacology;2020-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3